Services

Translational Science

NDA Advisory Board

Regulatory Affairs

Pharmacovigilance

High-Stakes Meetings

Spotlight

News

Regulatory strategies for value maximisation of early clinical stage assets

17th May 2018

Prepare for partnering – Optimizing value in early development.

More

Paula Salmikangas presents on Regulatory and scientific challenges for global development

11th May 2018

NDAs Dr Paula Salmikangas has been invited to present at the World Advanced Therapies and Regenerative Medicine Congress.

More

Professor Carole Longson to join NDA as Scientific Adviser

8th May 2018

We are pleased to announce that Professor Carole Longson has joined the NDA Advisory Board.

More

Free Webinar – Rational EU risk management for oncology medicines: time for a rethink

Join us on Thursday, 24th May to learn how you can implement the revised GVP module (V) concerning risk management in the interests of patients throughout the life-cycle of a medicine.

More

Is a global regulatory and market access strategy the way to go?

2nd May 2018

Dr. Thomas Lönngren, Strategic Advisor NDA Group and former Executive Director EMA, has been invited to present at the Chief Medical Officer Summit in Boston May 7th.

More

Seeking Parallel Consultation

23rd April 2018

Learn about the rationales and results of engaging early with regulators and HTA bodies in this white paper written by NDAs Dr. Mira Pavlovic-Ganascia and Claes Buxfeldt.

More

Meet us at PEGS Boston

19th April 2018

If you are planning to attend this year’s PEGS Boston, we would really like to meet up with you.

More
More News
We have helped over 2,000 clients achieve success in the past
We have helped over 2,000 clients achieve success in the past

The leader in FDA Advisory Committee meeting preparation

“For innovative life science companies, NDA and PharmApprove are the best partners to help prepare to win at FDA Advisory Committees. Our pioneering approach — refined over 16 years experience and 150-plus projects — has helped more than 80 clients achieve success at these high-profile, high-stakes hearings.

NDA Intelligence

Subscribe to the latest intelligence from the true thought leaders in the field and access it at any time.

Members

A Career with NDA

Join NDA and get the chance to work with some of the leading minds in regulatory affairs, pharmacovigilance, health technology assessment and scientific communications on a variety of projects, clients and geographies.

Join NDA and get the chance to work with some of the leading minds in regulatory affairs, pharmacovigilance,

Why work at NDA?

Our Locations

NDA Sweden

NDA Group AB
Johanneslundsv. 2
S-194 61 Upplands Väsby
Sweden

T. +46 (0)8 590 778 00
E. stockholm@ndareg.com

NDA France

7, rue Jobbé Duval,
75015 Paris,
France

T. +33 983 981 942
E. paris@ndareg.com

NDA Germany

Neumarkter Straße 18
D-81673 München
Germany

T. +49 (0)89 3585 4000
E. munich@ndareg.com

NDA Switzerland

Rigistrasse 5
8703 Erlenbach
Switzerland

T. +41 (0)78 951 9929
E. zurich@ndareg.com

NDA UK

Grove House
Guildford Road
Leatherhead,
Surrey KT22 9DF
United Kingdom

T. +44 (0) 1372 860 610
E. london@ndareg.com

NDA USA Massachusetts

NDA Regulatory Development Inc.
1 Broadway, 14th floor
Cambridge, MA 02142
United States

T. +1 609 583 1990
E. usa@ndareg.com

NDA USA New Jersey

PharmApprove
200 Princeton South Corporate Center,
Suite 340
Ewing, NJ 08628
United States

T. +1 609 583 1990
E. usa@ndareg.com